USA TODAY
Disclaimer: USA Today has partnered with AllSides and other bridging organizations, such as America Talks, to promote and support conversation events in which people on the left and right come together to bridge divides. This is work AllSides applauds and is a part of. This media bias rating page serves purely as an analysis of the bias of USA Today's news reporting; AllSides' bias analysis is independent, and partnerships with USA Today did not impact news bias analysis.
USA Today has published articles about AllSides' work, including:
USA Today has also published op-eds written by AllSides staff, including:
- Here's how technology can help reduce political polarization (Jan. 2020, CEO John Gable and Head Editor Henry A. Brechter)
- Political incivility is at crisis point in America. Here's how we can fix it (Nov. 2020, Brechter and COO Stephanie Bond).
- What Bruce Springsteen's Super Bowl ad gets right about reuniting Americans in 'the middle (Feb. 2021, Brechter)
Type of Content
Approved Story
1
Format
Region
News Item Format
Standard
The single-dose Johnson & Johnson vaccine that last week won approval from FDA advisers for a booster shot probably should have been a two-shot vaccine from the start, the nation's top infectious disease physician said Sunday.
"What the advisers to the FDA felt is that, given the data that they saw, very likely this should have been a two-dose vaccine to begin with," Dr. Anthony Fauci told ABC's "This Week."
The Food and Drug Administration vaccine advisory panel unanimously approved booster shots for the vaccine Friday for all J&J recipients 18 years and older – as early as two months after the first dose.
The panel's recommendations for the Moderna and Pfizer boosters were for Americans 65 and older or in higher risk groups.